XML 52 R43.htm IDEA: XBRL DOCUMENT v3.25.1
Note 11 - Related Party Transactions (Details Textual) - USD ($)
3 Months Ended 12 Months Ended
Apr. 09, 2025
Apr. 06, 2021
Jul. 10, 2017
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Jan. 01, 2025
Mar. 02, 2021
Mar. 01, 2021
Royalty Expense             $ 112,491 $ 115,692        
Professional Fees             $ 1,284,647 939,399        
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]             Prime Rate [Member]   Prime Rate [Member]      
Managing Director, China Operations [Member]                        
Deferred Compensation Arrangement with Individual, Compensation Expense             $ 5,000 5,000        
Consultant [Member]                        
Deferred Compensation Arrangement with Individual, Compensation Expense             $ 50,000 50,000        
Share-Based Payment Arrangement, Option [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)             0          
Director Clinical Affair [Member]                        
Royalty Expense             $ 112,000 116,000        
Professional Fees             39,000 39,000        
Director of Clinical Affairs [Member]                        
Accounts Payable and Accrued Liabilities, Current             $ 223,000   $ 110,000      
Mr. Osser, Interim Chief Executive Officer [Member]                        
Royalty on Net Sales, Percentage                     2.50% 5.00%
Mr. Osser, Vice Chairman of Board [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)   2,000,000                    
Shares Issued and Owned by Investors, Balance, Shares (in shares)             2,717,765          
Shares To Be Issued at Employment Termination (in shares)             2,481,048          
Mr. Osser, Vice Chairman of Board [Member] | Share-Based Payment Arrangement, Option [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)   5 years                    
Mr. Haverhals, Consultant and Director [Member]                        
Consulting Agreement, Annual Fee                   $ 350,000    
Payments for Consulting Services             $ 150,000          
Consulting Agreement, Compensation Expense             $ 150,000          
Shares To Be Issued after Employees Resignation (in shares)             912,736          
Mr. Haverhals, Consultant and Director [Member] | Forecast [Member]                        
Payments for Consulting Services       $ 66,666 $ 66,666 $ 66,666            
Mr. Neal Goldman, Ms. Benedetta Casamento, and Dr. Didier Demesmin [Member] | Forecast [Member]                        
Company Ownership Percentage 50.00%                      
Debt Instrument, Conversion Rate, Minimum Market Reference Price (in dollars per share) $ 0.5                      
Mr. Neal Goldman, Ms. Benedetta Casamento, and Dr. Didier Demesmin [Member] | Forecast [Member] | Promissory Note [Member]                        
Debt Instrument, Face Amount $ 800,000                      
Debt Instrument, Basis Spread on Variable Rate 2.50%                      
Debt Instrument, Equity Securities Issuance, Gross Proceeds Benchmark $ 4,000,000                      
Manufacturing Agreement for Handpieces [Member]                        
Related Party Transaction, Purchases from Related Party             $ 487,000 777,000        
Manufacturing Agreement for Handpieces [Member] | Related Party [Member] | Accounts Payable, Related Parties, Current [Member]                        
Accounts Payable and Accrued Liabilities             770,000   $ 663,000      
Employment Agreement [Member] | Mr. Osser, Vice Chairman of Board [Member]                        
Increase (Decrease) in Deferred Compensation     $ (100,000)                  
Employment Agreement, Base Compensation     200,000                  
Consulting Agreement [Member] | Mr. Osser, Vice Chairman of Board [Member]                        
Increase (Decrease) in Deferred Compensation     100,000                  
Employment Agreement, Base Compensation     $ 200,000                  
Purchased Medical Products [Member] | University Pain Medicine Center (STEMMEE) [Member]                        
Related Party Transaction, Amounts of Transaction             $ 6,000 $ 3,000